Page last updated: 2024-10-31

metyrapone and Vertigo

metyrapone has been researched along with Vertigo in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kley, HK1
Krüskemper, HL1
Sakashita, K1
Yokomi, Y1

Other Studies

2 other studies available for metyrapone and Vertigo

ArticleYear
[Performance and interpretation of a shortened metyrapone test].
    Klinische Wochenschrift, 1972, Nov-15, Volume: 50, Issue:22

    Topics: 11-Hydroxycorticosteroids; Acromegaly; Adolescent; Adult; Aged; Circadian Rhythm; Diabetes Mellitus;

1972
[Vertigo caused by SU 4885 (drug used in the hypophyseal function test)].
    Jibi inkoka Otolaryngology, 1971, Volume: 43, Issue:3

    Topics: Adult; Brain Injuries; Electrooculography; Female; Humans; Male; Metyrapone; Middle Aged; Pituitary

1971